propyl O-beta galactopyranosyl-(1-4)-O-beta galactopyranosyl-(1-4)-alpha galactopyranoside
structure given in first source
Also Known As:
PGGG; alpha-D-Galactopyranoside, propyl O-beta-D-galactopyranosyl-(1-4)-O-beta-D-galactopyranosyl-(1-4)-, (3beta)-
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Bermingham, Niamh:
1 article
(04/2007)
|
2. | Crowther, R Anthony:
1 article
(04/2007)
|
3. | Dlouhy, Stephen R:
1 article
(04/2007)
|
4. | Ghetti, Bernardino:
1 article
(04/2007)
|
5. | Goedert, Michel:
1 article
(04/2007)
|
6. | Keohane, Catherine:
1 article
(04/2007)
|
7. | Murrell, Jill R:
1 article
(04/2007)
|
8. | Spina, Salvatore:
1 article
(04/2007)
|
9. | Sweeney, Brian:
1 article
(04/2007)
|
10. | Yoshida, Hirotaka:
1 article
(04/2007)
|
Related Diseases
1. | Ideomotor Apraxia
|
2. | Neoplasm Metastasis (Metastasis)
01/01/2023
- " Multivariable Cox regression models in men with persistent PSA levels revealed that the %rPSA (HR, 8.92; 95% CI, 1.74-45.71; p=0.009) and pGGG 4-5 (HR, 4.13; 95% CI, 1.22-13.96; p=0.022) were independent predictors of distant metastasis, but not the fPSA level after surgery. " 01/01/2023
- " Multivariable Cox regression models of the overall cohort revealed that persistent PSA levels (hazard ratio [HR], 3.94; p=0.010), extracapsular extension (HR, 4.17; 95% confidence interval [CI], 1.06-16.41; p=0.041), and pathological Gleason grade group (pGGG) (HR, 3.69; 95% CI, 1.32-10.27; p=0.013) were independent predictors of metastasis. "
|
3. | Extranodal Extension
|
|